One of the major limitations of the use of phospho-diester oligonucleotides in cells is their rapid degradation by nucleases. To date, several chemical modi®cations have been employed to overcome this issue but insuf®cient ef®cacy and/or speci®city have limited their in vivo usefulness. In this work conformationally restricted nucleotides, locked nucleic acid (LNA), were investigated to design nuclease resistant aptamers targeted against the HIV-1 TAR RNA. LNA/DNA chimeras were synthe-sized from a shortened version of the hairpin RNA aptamer identi®ed by in vitro selection against TAR. The results indicate that these modi®cations confer good protection towards nuclease digestion. Electrophoretic mobility shift assays, thermal dena-turation ...
Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excelle...
Nucleic acid (NA) mimics show promise for sequence-unrestricted recognition of double-stranded (ds) ...
RNA-based drugs are an emerging class of therapeutics. They have the potential to regulate proteins,...
AbstractWe synthesized and evaluated by surface plasmon resonance 64 LNA/2′-O-methyl sequences corre...
The transactivation responsive element (TAR) plays a crucial role in the transcription of the HIV-1 ...
A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense,...
AbstractAptamers are RNA or DNA oligonucleotides identified within a randomly synthesized library, t...
Among numerous nucleic acid analogs reported in the past decades, locked nucleic acid (LNA) has rece...
A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense,...
AbstractWe have evaluated antisense design and efficacy of locked nucleic acid (LNA) and DNA oligonu...
Sequence-specific hybridization of antisense and antigene agent to the target nucleic acid is an imp...
Background: Modified nucleotides are increasingly being utilized in the de novo selection of aptamer...
selection of aptamers for enhancing their drug-like character and abolishing the need for time cons...
We have extracted from a random population of about 10<sup>9</sup> oligodeoxynucleotides a series of...
Aptamers are chimerized with drug or antisense oligos or nanoparticles to generate targeted therapeu...
Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excelle...
Nucleic acid (NA) mimics show promise for sequence-unrestricted recognition of double-stranded (ds) ...
RNA-based drugs are an emerging class of therapeutics. They have the potential to regulate proteins,...
AbstractWe synthesized and evaluated by surface plasmon resonance 64 LNA/2′-O-methyl sequences corre...
The transactivation responsive element (TAR) plays a crucial role in the transcription of the HIV-1 ...
A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense,...
AbstractAptamers are RNA or DNA oligonucleotides identified within a randomly synthesized library, t...
Among numerous nucleic acid analogs reported in the past decades, locked nucleic acid (LNA) has rece...
A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense,...
AbstractWe have evaluated antisense design and efficacy of locked nucleic acid (LNA) and DNA oligonu...
Sequence-specific hybridization of antisense and antigene agent to the target nucleic acid is an imp...
Background: Modified nucleotides are increasingly being utilized in the de novo selection of aptamer...
selection of aptamers for enhancing their drug-like character and abolishing the need for time cons...
We have extracted from a random population of about 10<sup>9</sup> oligodeoxynucleotides a series of...
Aptamers are chimerized with drug or antisense oligos or nanoparticles to generate targeted therapeu...
Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excelle...
Nucleic acid (NA) mimics show promise for sequence-unrestricted recognition of double-stranded (ds) ...
RNA-based drugs are an emerging class of therapeutics. They have the potential to regulate proteins,...